Asia-pacific Clinical Trials Support Services Market Forecast 2022-2030

The Asia-Pacific clinical trials support services market is estimated to surge with an 8.21% CAGR over the assessment period, 2022 and 2030. The availability of high-quality data at a low price and the presence of a huge population drive market growth.

MARKET INSIGHTS

The Asia-Pacific clinical trials support services market growth evaluation entails the analysis of Japan, China, Singapore, South Korea, Taiwan, India, Australia & New Zealand, Thailand, and Rest of Asia-Pacific. In India, clinical trials are surging. Therefore, clinical trial support services are expected to propel in the next few years. Further, in 2020, there were various top therapy areas for industry-sponsored clinical trials in India, which helped to support the demand for clinical trials during the forecast period.

South Korea has emerged as an attractive country to conduct clinical trials because it offers clinical experts who conduct the clinical trials, infrastructure, dense population, supportive government regulations, etc. Sponsors prefer conducting clinical trials in South Korea due to its speed and quality. With the high density of the population, patients are easily available for participation and the advanced hospitals available in the country. South Korea has an added advantage with access to a larger population.

On the other hand, in Taiwan, the development of the international biotechnology industry is increasing rapidly. Different types of research and development have been advanced to the clinical trial stage. Also, the competition is rising between Japan and South Korea, and as a result, the Taiwan government set up a one-stop shop to provide domestic and international partners with key information on Taiwan's clinical trial environment.

COMPETITIVE INSIGHTS

Some key market players include: EPS Corporation, CMIC Group, WuXi AppTec, etc.

Our report offerings include:

Explore key findings of the overall market

Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

Market Segmentation caters to a thorough assessment of key segments with their market estimations

Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 47762

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. RISING PREVALENCE OF CHRONIC DISEASE & VIRUS OUTBREAKS
- 3.1.2. BENEFITS OF CLINICAL TRIAL SUPPORT SERVICES
3.2. KEY RESTRAINTS
- 3.2.1. AVAILABILITY OF OPEN-SOURCE/FREEWARE SOFTWARE
- 3.2.2. STRINGENT REGULATIONS

4. KEY ANALYTICS

4.1. IMPACT OF COVID-19 ON CLINICAL TRIALS SUPPORT SERVICES MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
4.6. VALUE CHAIN ANALYSIS
4.7. KEY BUYING CRITERIA
- 4.7.1. PERFORMANCE
- 4.7.2. EASE OF USE
- 4.7.3. SECURITY
- 4.7.4. COST-EFFECTIVENESS
4.8. REGULATORY FRAMEWORK

5. MARKET BY PHASE

5.1. PHASE I
5.2. PHASE II
5.3. PHASE III
5.4. PHASE IV

6. MARKET BY SPONSOR

6.1. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
6.2. MEDICAL DEVICE COMPANIES
6.3. OTHER SPONSORS

7. MARKET BY SERVICE

7.1. CLINICAL TRIAL SITE MANAGEMENT
7.2. ADMINISTRATIVE STAFF
7.3. PATIENT RECRUITMENT MANAGEMENT
- 7.3.1. PATIENT RECRUITMENT & REGISTRY SERVICES
- 7.3.2. PATIENT RETENTION
- 7.3.3. OTHER PATIENT RECRUITMENT MANAGEMENT
7.4. IRB
7.5. DATA MANAGEMENT
7.6. OTHER SERVICES

8. GEOGRAPHICAL ANALYSIS

8.1. ASIA-PACIFIC
- 8.1.1. MARKET SIZE & ESTIMATES
- 8.1.2. KEY GROWTH ENABLERS
- 8.1.3. KEY CHALLENGES
- 8.1.4. KEY PLAYERS
- 8.1.5. COUNTRY ANALYSIS
  - 8.1.5.1. CHINA
  - 8.1.5.2. JAPAN
  - 8.1.5.3. INDIA
  - 8.1.5.4. SOUTH KOREA
  - 8.1.5.5. TAIWAN
  - 8.1.5.6. SINGAPORE
  - 8.1.5.7. THAILAND
  - 8.1.5.8. AUSTRALIA & NEW ZEALAND
  - 8.1.5.9. REST OF ASIA-PACIFIC

9. COMPETITIVE LANDSCAPE

9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. MERGERS & ACQUISITIONS
- 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 9.1.3. PARTNERSHIPS & AGREEMENTS
- 9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
- 9.2.1. ADVANCED CLINICAL
- 9.2.2. ALCURA
- 9.2.3. CHARLES RIVER LABORATORIES INC
- 9.2.4. CLINIPACE
- 9.2.5. CTI CLINICAL TRIAL AND CONSULTING SERVICES INC
- 9.2.6. ICON PLC
- 9.2.7. IQVIA
- 9.2.8. KCR
- 9.2.9. LABCORP DRUG DEVELOPMENT
- 9.2.10. MEDPACE
- 9.2.11. PAREXEL
- 9.2.12. PSI CRO
- 9.2.13. SYNEOS HEALTH
- 9.2.14. WORLDWIDE CLINICAL TRIALS
- 9.2.15. WUXI APPTEC

Product Code: 47762

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - CLINICAL TRIALS SUPPORT SERVICES
TABLE 2: LIST OF PANDEMIC OUTBREAKS
TABLE 3: LIST OF OPEN-SOURCE SOFTWARE
TABLE 4: LIST OF PARTNERSHIPS
TABLE 5: LAUNCH OF MEDICAL DRUGS
TABLE 6: PROMISING ACQUISITIONS IN THE INDUSTRY
TABLE 7: REGULATORY FRAMEWORK
TABLE 8: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 13: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 14: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 15: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 16: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 17: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 18: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET
TABLE 19: LIST OF MERGERS & ACQUISITIONS
TABLE 20: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 21: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 22: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: VALUE CHAIN ANALYSIS
FIGURE 6: KEY BUYING CRITERIA
FIGURE 7: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY PHASE, IN 2021
FIGURE 8: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2030 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II, 2022-2030 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III, 2022-2030 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV, 2022-2030 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY SPONSOR, IN 2021
FIGURE 13: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2022-2030 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE COMPANIES, 2022-2030 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS, 2022-2030 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY SERVICE, IN 2021
FIGURE 17: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL SITE MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE STAFF, 2022-2030 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY PATIENT RECRUITMENT MANAGEMENT, IN 2021
FIGURE 21: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT & REGISTRY SERVICES, 2022-2030 (IN $ MILLION)
FIGURE 22: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RETENTION, 2022-2030 (IN $ MILLION)
FIGURE 23: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER PATIENT RECRUITMENT MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 24: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY IRB, 2022-2030 (IN $ MILLION)
FIGURE 25: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 26: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES, 2022-2030 (IN $ MILLION)
FIGURE 27: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 28: CHINA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 29: JAPAN CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 30: INDIA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 31: SOUTH KOREA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 32: TAIWAN CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 33: SINGAPORE CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 34: THAILAND CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 35: AUSTRALIA & NEW ZEALAND CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 36: REST OF ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)